BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $9.43 million. The enterprise value is -$10.80 million.
Important Dates
The last earnings date was Friday, February 6, 2026, after market close.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 415.78% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +415.78% |
| Shares Change (QoQ) | +51.90% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 17.41% |
| Float | 7.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.25, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.25 |
| Quick Ratio | 6.90 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,013.77 |
Financial Efficiency
Return on equity (ROE) is -80.74% and return on invested capital (ROIC) is -51.84%.
| Return on Equity (ROE) | -80.74% |
| Return on Assets (ROA) | -47.20% |
| Return on Invested Capital (ROIC) | -51.84% |
| Return on Capital Employed (ROCE) | -93.34% |
| Weighted Average Cost of Capital (WACC) | 7.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.34M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.55% in the last 52 weeks. The beta is 0.56, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -91.55% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 4.01 |
| Relative Strength Index (RSI) | 51.60 |
| Average Volume (20 Days) | 114,475 |
Short Selling Information
The latest short interest is 194,765, so 2.58% of the outstanding shares have been sold short.
| Short Interest | 194,765 |
| Short Previous Month | 153,081 |
| Short % of Shares Out | 2.58% |
| Short % of Float | 2.60% |
| Short Ratio (days to cover) | 1.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.20M |
| Pretax Income | -17.43M |
| Net Income | -17.48M |
| EBITDA | -17.97M |
| EBIT | -18.20M |
| Earnings Per Share (EPS) | -$4.15 |
Full Income StatementBalance Sheet
The company has $20.54 million in cash and $314,915 in debt, with a net cash position of $20.23 million or $2.68 per share.
| Cash & Cash Equivalents | 20.54M |
| Total Debt | 314,915 |
| Net Cash | 20.23M |
| Net Cash Per Share | $2.68 |
| Equity (Book Value) | 19.27M |
| Book Value Per Share | 2.55 |
| Working Capital | 18.79M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
